title: Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors.
authors.forename: E
authors.initials: E
authors.lastname: Traer
authors.forename: R
authors.initials: R
authors.lastname: MacKenzie
authors.forename: J
authors.initials: J
authors.lastname: Snead
authors.forename: A
authors.initials: A
authors.lastname: Agarwal
authors.forename: A M
authors.initials: AM
authors.lastname: Eiring
authors.forename: T
authors.initials: T
authors.lastname: O'Hare
authors.forename: B J
authors.initials: BJ
authors.lastname: Druker
authors.forename: M W
authors.initials: MW
authors.lastname: Deininger
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors*; D020014:K562 Cells; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology*; D016374:Oncogene Proteins v-abl / Q000037:antagonists & inhibitors*
chemical_list: D000970:Antineoplastic Agents; D016374:Oncogene Proteins v-abl; C507924:JAK2 protein, human; D053614:Janus Kinase 2
references.citation: Blood. 1995 Feb 15;85(4):997-1005
references.pmid: 7849321
references.citation: Lancet Oncol. 2010 Nov;11(11):1029-35
references.pmid: 20965785
references.citation: Blood. 2001 Apr 1;97(7):2008-15
references.pmid: 11264165
references.citation: Leukemia. 2009 Aug;23(8):1441-5
references.pmid: 19295546
references.citation: Oncogene. 2007 Oct 15;26(47):6724-37
references.pmid: 17934481
references.citation: Blood. 1998 Nov 15;92(10):3780-92
references.pmid: 9808572
references.citation: Genes Cancer. 2010 Apr;1(4):346-59
references.pmid: 20798787
references.citation: Blood. 2006 Jun 1;107(11):4532-9
references.pmid: 16469872
references.citation: Blood. 2007 May 1;109(9):4016-9
references.pmid: 17213283
references.citation: Cancer Cell. 2005 Feb;7(2):129-41
references.pmid: 15710326
references.citation: J Clin Invest. 2011 Jan;121(1):396-409
references.pmid: 21157039
references.citation: Leukemia. 2010 Apr;24(4):771-8
references.pmid: 20130598
references.citation: Blood. 2007 Mar 1;109(5):2147-55
references.pmid: 17090651
references.citation: Blood. 1998 Nov 15;92(10):3829-40
references.pmid: 9808576
references.citation: Mol Cancer Ther. 2008 May;7(5):1121-9
references.pmid: 18445657
references.citation: Mol Cancer Ther. 2008 Oct;7(10):3169-75
references.pmid: 18852120
references.citation: Blood. 2009 Aug 6;114(6):1150-7
references.pmid: 19401558
references.citation: Leukemia. 2007 Aug;21(8):1658-68
references.pmid: 17541402